Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What You Need To Know Ahead of Solventum Earnings Release

Solventum Corporation (SOLV) is a healthcare company that develops, manufactures, and commercializes a broad portfolio of medical, surgical, dental and health information technology products and services for customers and patients. The company was spun off from 3M’s healthcare division in April 2024, inheriting decades of established healthcare expertise and operations. Solventum is headquartered in Maplewood, Minnesota and has a market cap of $13.9 billion.

The healthcare company is expected to announce its fiscal fourth-quarter earnings for 2025 soon. Ahead of the event, analysts expect SOLV to report a profit of $1.50 per share on a diluted basis, up 6.4% from $1.41...

Fundamentals

See More
  • Market Capitalization, $K 13,940,015
  • Shares Outstanding, K 173,448
  • Annual Sales, $ 8,254 M
  • Annual Income, $ 478,000 K
  • EBIT $ 2,192 M
  • EBITDA $ 2,747 M
  • 60-Month Beta 0.34
  • Price/Sales 1.67
  • Price/Cash Flow 7.94
  • Price/Book 2.75

Options Overview Details

View History
  • Implied Volatility 25.39% (-0.29%)
  • Historical Volatility 28.39%
  • IV Percentile 10%
  • IV Rank 11.24%
  • IV High 62.22% on 04/10/25
  • IV Low 20.73% on 12/26/25
  • Expected Move (DTE 29) 3.86 (4.77%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 230
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 5,578
  • Open Int (30-Day) 6,618
  • Expected Range 76.98 to 84.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.50
  • Number of Estimates 5
  • High Estimate 1.51
  • Low Estimate 1.49
  • Prior Year 1.41
  • Growth Rate Est. (year over year) +6.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.18 +3.07%
on 01/05/26
86.36 -6.69%
on 01/09/26
-0.20 (-0.24%)
since 12/22/25
3-Month
66.11 +21.89%
on 11/06/25
88.20 -8.64%
on 12/02/25
+7.82 (+10.75%)
since 10/22/25
52-Week
60.70 +32.76%
on 04/09/25
88.20 -8.64%
on 12/02/25
+6.92 (+9.40%)
since 01/22/25

Most Recent Stories

More News
What You Need To Know Ahead of Solventum Earnings Release

Solventum is expected to release its fiscal fourth-quarter earnings soon, and analysts project a modest earnings increase.

SOLV : 81.15 (+0.97%)
XLV : 158.84 (+0.37%)
$SPX : 6,900.86 (+0.37%)
3 Reasons SOLV is Risky and 1 Stock to Buy Instead

3 Reasons SOLV is Risky and 1 Stock to Buy Instead

SOLV : 81.15 (+0.97%)
Solventum Completes Acquisition of Acera Surgical

ST. PAUL, Minn. , Dec. 23, 2025 /PRNewswire/ -- Solventum  (NYSE: SOLV) announced today it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company...

SOLV : 81.15 (+0.97%)
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy

New guidance highlights evolving surgical procedure applications of reticulated open cell foam (ROCF) dressings to support patient safety, surgical outcomes and future standards of care

SOLV : 81.15 (+0.97%)
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

ST. PAUL, Minn. , Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it has achieved the Diamond Level Resiliency Badge from the Healthcare Industry Resilience Collaborative...

SOLV : 81.15 (+0.97%)
Is Solventum Stock Outperforming the Nasdaq?

Solventum has delivered stronger performance than the Nasdaq Composite over the past year, reinforcing analysts’ moderate optimism regarding the stock’s forward outlook.

SOLV : 81.15 (+0.97%)
$NASX : 23,359.90 (+0.58%)
BDX : 206.00 (-0.09%)
Kellanova Stock Is No More. Should Consumer Packaged Goods Fans Buy Shares of This Blue-Chip Stock Instead?

This Buffett stock has been one of his few misfires, and that situation doesn't look poised to change.

SOLV : 81.15 (+0.97%)
BRK.A : 724,865.94 (+0.11%)
KHC : 22.49 (+0.40%)
BRK.B : 482.47 (-0.28%)
GEV : 650.56 (-2.59%)
3 Value Stocks with Open Questions

3 Value Stocks with Open Questions

SOLV : 81.15 (+0.97%)
CAG : 17.44 (+0.81%)
MAN : 31.23 (+2.90%)
1 Mid-Cap Stock on Our Buy List and 2 We Question

1 Mid-Cap Stock on Our Buy List and 2 We Question

SOLV : 81.15 (+0.97%)
AVY : 185.70 (-0.09%)
NXT : 103.88 (+3.55%)
1 Unpopular Stock That Should Get More Attention and 2 We Ignore

1 Unpopular Stock That Should Get More Attention and 2 We Ignore

SOLV : 81.15 (+0.97%)
CL : 84.52 (-0.25%)
IVZ : 29.19 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

See More

Key Turning Points

3rd Resistance Point 83.13
2nd Resistance Point 82.08
1st Resistance Point 81.23
Last Price 81.15
1st Support Level 79.32
2nd Support Level 78.26
3rd Support Level 77.41

See More

52-Week High 88.20
Last Price 81.15
Fibonacci 61.8% 77.69
Fibonacci 50% 74.45
Fibonacci 38.2% 71.20
52-Week Low 60.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar